Real-Time Adaptive Guidance for Enhanced Targeted Therapy
Software Facilitates Adaptive Radiotherapy
Novel Lung Simulator Helps Oncologists Deliver Radiation More Precisely
SegAna Helps Oncologists Deliver Radiation More Precisely
Innovation Dedicated to Saving Lives for Patients with Lung Cancer
4D Lung Phantoms Uploaded with Patient Specific Breathing Parameters
Created for Targeted Therapy and Enhancing Radiation Treatment
SegAna LLC is a medical device company that has developed a cloud-based software platform for enhancing radiation treatment of cancer.
The company’s patent pending state of the art technology will enhance the treatment of cancer by providing the Radiation Oncology Team, in any setting or location, with the ability to quickly and accurately define the margin of the tumor on the day of treatment, which will ultimately reduce radiation damage to the tissue surrounding the tumor and improve the patient’s outcome.
The company’s patent pending state-of-the-art technology enhances the treatment of cancer by providing radiation oncologists with the guidance to accurately delineate the tumor location on the day of treatment. Reducing radiation damage to the surrounding tissues or organs tissue, may lead to an improved patient outcome.
Mission and Vision
SegAna LLC was founded to provide all Radiation Oncology teams, regardless of the setting, with the most accurate, real-time, adaptive treatment guidance. Our mission is to improve radiation treatment efficacy and a patient’s quality of life through proven, measurable technology. SegAna seeks to transform patient outcomes through better targeting and delivery of radiation therapies, to provide an on-demand, affordable access for all patients with cancer, and deliver proven results.